Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
59,000
Employees59,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
59,000
Employees59,000

BSX Key Statistics

Market cap
92.39B
Market cap92.39B
Price-Earnings ratio
32.45
Price-Earnings ratio32.45
Dividend yield
Dividend yield
Average volume
15.95M
Average volume15.95M
High today
$63.91
High today$63.91
Low today
$61.44
Low today$61.44
Open price
$63.71
Open price$63.71
Volume
19.03M
Volume19.03M
52 Week high
$109.50
52 Week high$109.50
52 Week low
$61.25
52 Week low$61.25

Stock Snapshot

Boston Scientific(BSX) stock is priced at $62.27, giving the company a market capitalization of 92.39B. It carries a P/E multiple of 32.45.

As of 2026-03-31, Boston Scientific(BSX) stock has fluctuated between $61.44 and $63.91. The current price stands at $62.27, placing the stock +1.3% above today's low and -2.6% off the high.

Boston Scientific(BSX) shares are trading with a volume of 19.03M, against a daily average of 15.95M.

During the past year, Boston Scientific(BSX) stock moved between $61.25 at its lowest and $109.50 at its peak.

During the past year, Boston Scientific(BSX) stock moved between $61.25 at its lowest and $109.50 at its peak.

BSX News

Simply Wall St 9h
Is There An Opportunity In Boston Scientific After Steep Recent Share Price Declines?

If you are wondering whether Boston Scientific at around US$62.93 still offers value, the key question is how its current price lines up with the cash flows and...

Is There An Opportunity In Boston Scientific After Steep Recent Share Price Declines?
Nasdaq 22h
Stock Market Today, March 30: Boston Scientific Falls After Delivering Underwhelming Trial Results

Boston Scientific (NYSE:BSX), a maker of medical devices for interventional specialties, closed Monday at $62.92, down 9.03%. The stock moved lower on Monday as...

Stock Market Today, March 30: Boston Scientific Falls After Delivering Underwhelming Trial Results
Barron's 1d
Boston Scientific Stock Sinks to 2-Year Low. Why Wall Street Is Souring on Trial Data.

Feature Boston Scientific Stock Sinks to 2-Year Low. Why Wall Street Is Souring on Trial Data. In this article BSX SPX Boston Scientific stock was on pace for i...

Boston Scientific Stock Sinks to 2-Year Low. Why Wall Street Is Souring on Trial Data.

Analyst ratings

97%

of 37 ratings
Buy
97.3%
Hold
2.7%
Sell
0%

More BSX News

TipRanks 1d
FTC issued Second Request to Penumbra, Boston Scientific over merger review

According to a regulatory filing, Penumbra (PEN) and Boston Scientific (BSX) each filed a notification and report form under the HSR Act with the DOJ and the FT...

Benzinga 1d
Boston Scientific Drops Despite Encouraging Trial Readouts

WATCHMAN FLX Shows Bleeding Advantage, Matches Efficacy The CHAMPION-AF study results shared on Saturday highlighted the WATCHMAN FLX device’s efficacy compare...

Boston Scientific Drops Despite Encouraging Trial Readouts
TipRanks 1d
Boston Scientific upside scenario unlikely after data, says Wells Fargo

Wells Fargo says that while Boston Scientific’s (BSX) CHAMPION-AF trial met its endpoints, the data is unlikely to accelerate Watchman growth given a slightly h...

TipRanks 2d
Buy Rating on Boston Scientific’s Watchman FLX Backed by Champion Trial Success and Accelerating LAAC Market Growth

Analyst Josh Jennings from TD Cowen maintained a Buy rating on Boston Scientific and keeping the price target at $100.00. Unlock hedge fund-level data and powe...

TipRanks 2d
Boston Scientific announces Champion-AF trial met primary, secondary endpoints

Boston Scientific (BSX) announced that the Champion-AF global clinical trial met all primary and secondary safety and efficacy endpoints. The study evaluated th...

Simply Wall St 4d
Boston Scientific Valuation Check As Electrophysiology Concerns And Lawsuit Weigh On Sentiment

Boston Scientific (BSX) stock has come under pressure after a class action lawsuit accused the company of misleading investors about its Electrophysiology growt...

Boston Scientific Valuation Check As Electrophysiology Concerns And Lawsuit Weigh On Sentiment
TipRanks 5d
Boston Scientific price target lowered to $93 from $98 at Goldman Sachs

Goldman Sachs lowered the firm’s price target on Boston Scientific (BSX) to $93 from $98 but keeps a Buy rating on the shares. The firm is revising its base cas...

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.